TELA
Tela Bio IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$39.85M
P/E Ratio
—
EPS
$-0.79
Beta
1.30
52W High
$2.20
52W Low
$0.50
50-Day MA
$0.78
200-Day MA
$1.13
Dividend Yield
—
Profit Margin
-49.30%
Forward P/E
—
PEG Ratio
—
About Tela Bio Inc
TELA Bio, Inc., a medical technology company, focuses on the design, development and commercialization of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company is headquartered in Malvern, Pennsylvania.
Fundamentals
| Revenue (TTM) | $80.81M |
| Gross Profit (TTM) | $54.73M |
| EBITDA | $-32.81M |
| Operating Margin | -55.20% |
| Return on Equity | -617.00% |
| Return on Assets | -28.70% |
| Revenue/Share (TTM) | $1.62 |
| Book Value | $0.14 |
| Price-to-Book | 7.30 |
| Price-to-Sales (TTM) | 0.49 |
| EV/Revenue | 0.703 |
| EV/EBITDA | -5.01 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 2.90% |
| Shares Outstanding | $44.77M |
| Float | $19.48M |
| % Insiders | 8.42% |
| % Institutions | 68.98% |
Historical Volatility
HV 10-Day
100.89%
HV 20-Day
134.33%
HV 30-Day
123.48%
HV 60-Day
119.44%
HV Rank
91.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($2.25 target)
1
Strong Buy3
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026